CURA Diagnostics has experienced a year of significant achievements and advancements. A standout among these triumphs has been the successful launch of DOA20 and comprehensive lab solutions, implemented across multiple laboratories. As we eagerly anticipate the unveiling of new products later this year, it is essential to acknowledge the instrumental role played by Dr. Juehua Yu in driving these accomplishments.

Joining CURA in April 2023 as the EVP of Business Development, Dr. Yu has been a catalyst for growth and innovation. His strategic vision and dedication to building professional relationships, both within the organization and externally, have been instrumental in shaping CURA's success story. Dr. Yu's ability to forge partnerships with suppliers and end-users alike has significantly contributed to the company's expansion and impact in the diagnostics industry.

In recognition of his outstanding contributions, CURA Dx is thrilled to announce the well-deserved promotion of Dr. Juehua Yu to the position of Chief Operating Officer. This appointment reflects not only his leadership skills but also his unwavering commitment to the company's mission and values. Dr. Yu's ascent to this pivotal role is a testament to the exceptional talent and expertise he brings to the organization.

As we embark on this exciting journey with Dr. Yu as our Chief Operating Officer, we express our gratitude for his remarkable leadership and look forward to reaching new heights under his guidance. CURA Dx is privileged to have such a powerful and forward-thinking leader at the helm, and we are confident that this promotion marks the beginning of a new chapter filled with continued success and innovation.